F

FibroGen

487 employees

FibroGen uses its expertise in CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Anemia
Duchenne Muscular Dystrophy
Biopharma
Fibrotic Disease
HIF-PHI
Health Care
Therapeutics
Chronic Kidney Disease
Pancreatic Cancer
Anti-CTGF
Idiopathic Pulmonary Fibrosis

Date founded

1993

FAQ